The Valley Desk

NCT01903811 · Interventional trial

S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma

Overall registry status Completed

Phase 2

Conditions Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov